# Erode Cancer Centre – FDA Inspection, Nov 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/erode-cancer-centre/286c4388-daec-4f68-a188-fa7cde16104d
Source feed: FDA_Inspections

> FDA inspection 1231825 of Erode Cancer Centre, November 21, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231825
- Company Name: Erode Cancer Centre
- Inspection Date: 2023-11-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1121547 - 2020-02-28
- FDA Inspection 1004974 - 2017-02-24

## Related Officers

- [Company Rep](https://www.keypedia.com/people/courtney-n-long/32118415-bc77-4ac2-8f90-947e43cf10ff)

Company: https://www.keypedia.com/companies/erode-cancer-centre/8d952bcb-5a81-4637-9f8f-55b3c4c600d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c